What Actually Happens When You Join a Trial
There is a gap between what people imagine and what a clinical trial actually involves. Most trials are not inpatient stays in a hospital ward. They are a series of outpatient visits—screening first, then regular check-ins over weeks or months—where researchers track lung function, symptom scores, and sometimes blood biomarkers.
A typical asthma trial follows this rhythm. You show up for a screening visit where the team confirms your diagnosis, runs a pulmonary function test, and checks whether you meet the inclusion criteria. Eligibility often hinges on things like your current medication regimen, your exacerbation history over the past year, and whether your asthma is eosinophilic (a subtype driven by high levels of eosinophils, a type of white blood cell). Some trials require a blood eosinophil count above a certain threshold; others are designed to work regardless of biomarker levels.
If you qualify, you enter a treatment period. Depending on the study design, you might receive the investigational drug, a placebo, or a standard-of-care comparator. Placebo-controlled trials are common in Phase 2 and Phase 3 research, but many participants find the trade-off acceptable because they continue their regular maintenance medications throughout the study. You are not being asked to stop your current treatment and hope for the best.
Each visit involves a check-in with the study coordinator, spirometry testing, and sometimes blood draws. Some trials ask participants to keep a daily asthma diary. The 2026 Seabreeze STAT Asthma trial, for example, is evaluating rademikibart in patients experiencing an acute asthma exacerbation and tracking treatment failure rates within 28 days. Eli Lilly's RENEW-Asthma study, with 121 locations across the U.S., is testing brenipatide over a 52-week treatment period.
Then there is the compensation question. Payment varies widely but is not trivial. Clinical Research of West Florida offers up to $1,100 for asthma trial participation. The University of Wisconsin has studies paying up to $1,350. Brigham and Women's Hospital Asthma Research Center offers up to $3,900 for participants who complete 26 onsite visits over 22 months. Shorter focus groups and surveys tend to fall in the $100–$350 range. These payments are typically structured as stipends for time and travel, not as payment for taking on medical risk.
| Study Type | Example | Typical Compensation Range | Time Commitment | Best For | Key Consideration |
|---|
| Phase 2 Biologic Trial | RENEW-Asthma (brenipatide) | $1,000–$3,000 | 12–16 months | Moderate-to-severe asthma not controlled on current therapy | May involve placebo arm; requires frequent clinic visits |
| Phase 3/4 Real-World Study | PASSAGE (tezepelumab) | $500–$2,000 | 6–24 months | Patients underrepresented in traditional trials | Less restrictive eligibility; real-world dosing schedules |
| Repurposed Drug Trial | TRIM (roflumilast), MINA (metformin) | $500–$1,500 | 6–12 months | Overweight/obese adults with poorly controlled asthma | Drugs already have known safety profiles from other indications |
| Focus Group / Survey | Inhaler usability studies | $100–$350 | 1–2 sessions | Anyone with an asthma diagnosis | Short commitment; no treatment involved |
| Observational Study | DLP-LHC (Johns Hopkins) | $200–$800 | 1–5 visits | Those wanting to contribute to research without taking an experimental drug | No intervention; lung function phenotyping only |
Finding a Trial That Fits
The most straightforward starting point is ClinicalTrials.gov, a database maintained by the National Library of Medicine. You can search by condition ("asthma"), location (your city or state), and recruitment status ("recruiting"). The site lists every registered trial in the country, but it can feel overwhelming—hundreds of asthma studies appear, many of them completed or no longer enrolling.
A more curated approach is to go through the American Lung Association's clinical trial finder, which highlights actively recruiting studies at its ACRC network. These trials tend to be well-vetted and patient-centered. University medical centers are another reliable gateway. Johns Hopkins, UCSF, Boston Children's Hospital, and many others maintain searchable trial databases on their websites. If you live near a major research hospital, you can often find a study coordinator's direct phone number and email—a real person who will walk you through the screening process.
For people with severe asthma who have tried multiple biologics without lasting success, academic medical centers are particularly worth contacting. These institutions are running the comparative effectiveness studies that ask nuanced questions: Does dupilumab improve lung function more than benralizumab in certain patient subgroups? The EU-ADVANTAGE study and similar U.S.-based analyses are generating answers that directly inform treatment decisions.
What about the cost? Participating in a clinical trial generally does not require you to pay for the investigational drug or study-related procedures. The sponsor—usually a pharmaceutical company, a university, or a government agency like the NIH—covers these costs. Your regular health insurance may still be billed for standard-of-care components, so it is worth asking the study coordinator upfront about any potential out-of-pocket expenses before you enroll.
Who Can Join and What to Expect
Eligibility criteria vary by study, but some patterns hold across most asthma trials. Researchers typically look for adults aged 18 and older with a confirmed asthma diagnosis, though some trials now include adolescents as young as 12. A history of exacerbations—often defined as one or more courses of oral corticosteroids, ER visits, or hospitalizations in the past year—is a common requirement for severe asthma trials. Current medication use matters: many studies require participants to be on medium-to-high-dose inhaled corticosteroids with a long-acting beta-agonist and still have uncontrolled symptoms.
The screening process itself can be educational. During the pulmonary function tests and blood work, you may learn specifics about your asthma subtype that your regular doctor has not tested for—like your eosinophil count or fractional exhaled nitric oxide levels. Even if you do not qualify for the trial, walking away with that data can help guide your ongoing care.
One concern that comes up repeatedly is the possibility of receiving a placebo. It is a legitimate worry. In placebo-controlled trials, you might not get the active treatment. But the study team is required to explain exactly what the randomization looks like before you sign the consent form. Some trials use an "add-on" design, meaning the investigational drug or placebo is added to your existing maintenance therapy. Others have an open-label extension phase after the blinded portion ends, guaranteeing all participants eventual access to the active treatment.
The informed consent document is long—often 15 to 20 pages—and it spells out every known risk, every procedure, and your right to withdraw at any time. Take it home. Read it. Ask questions. The study coordinator expects this and a good one will answer without rushing you.
Making Sense of the Options
Rebecca, a 42-year-old teacher in Phoenix, spent months searching for "asthma clinical trials near me" before finding the University of Arizona's Asthma and Airway Disease Research Center. She enrolled in a study after her insurance stopped covering one of her biologic prescriptions. The trial gave her access to a medication she could not otherwise afford, and the research team caught a decline in her lung function during a routine visit that her primary care doctor might have missed.
That kind of monitoring is not incidental. Trial participants receive more frequent and detailed assessments than most patients get in routine clinical practice. For someone whose asthma has been difficult to stabilize, the extra attention can be as valuable as the experimental treatment itself.
Still, clinical trials are not for everyone. They require time, travel, and a willingness to sit with uncertainty. Not every investigational drug works. Some have side effects that only emerge in larger populations. The decision to participate is personal and should involve a conversation with your current healthcare provider—not just the research team.
The most practical step you can take today is to browse the trials recruiting in your area. The American Lung Association's website lists studies by state and city. ClinicalTrials.gov lets you filter by distance from your ZIP code. Major academic centers like Johns Hopkins, UCSF, Duke, Northwestern, and Mount Sinai all have dedicated clinical trial search tools. If you see a study that sounds relevant, call or email the contact listed. The screening call is informal, and there is no obligation to enroll. At minimum, you will learn more about what is happening in asthma research and whether a trial might fit into your treatment plan somewhere down the line.
研究の知恵